ABSTRACT
Containment technology reaches across the entire health care spectrum, ranging from discovery to patient delivery. New drugs and delivery systems for drugs require the two critical elements that containment (or isolation) technology provides, namely, protection of the product and protection of personnel who produce the drugs. Since drugs are becoming more potent, exposure to small amounts can result in deleterious effects. Innovative delivery technologies create an even greater challenge, with final dosage forms that focus on specific targets in the body, creating a higher risk of exposure for health care personnel involved in the delivery of these drug forms to the intended patient.
